Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence"

Mathias Ørholt; Frank Eriksson; Mikkel Herly; Peter Vester-Glowinski

doi:10.1016/j.jaad.2023.12.042

Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence"

Mathias Ørholt, Frank Eriksson, Mikkel Herly, Peter Vester-Glowinski

Research output: Contribution to journal › Comment/debate › Research › peer-review

Abstract

To the Editor: We thank Pham et al1 for their interest in our study on patients with atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS),2 and we appreciate the opportunity to discuss and clarify our analysis further.

Original language	English
Journal	Journal of the American Academy of Dermatology
Volume	90
Issue number	5
Pages (from-to)	e175-e176
Number of pages	2
ISSN	0190-9622
DOIs	https://doi.org/10.1016/j.jaad.2023.12.042
Publication status	Published - 2024

Access to Document

10.1016/j.jaad.2023.12.042

Cite this

Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence". / Ørholt, Mathias; Eriksson, Frank ; Herly, Mikkel et al.
In: Journal of the American Academy of Dermatology, Vol. 90, No. 5, 2024, p. e175-e176.

Research output: Contribution to journal › Comment/debate › Research › peer-review

@article{dfa3b4e92e0d4dcb93651f762429bbd4,

title = "Response to Pham et al., {"}More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence{"}",

abstract = "To the Editor: We thank Pham et al1 for their interest in our study on patients with atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS),2 and we appreciate the opportunity to discuss and clarify our analysis further.",

author = "Mathias {\O}rholt and Frank Eriksson and Mikkel Herly and Peter Vester-Glowinski",

year = "2024",

doi = "10.1016/j.jaad.2023.12.042",

language = "English",

volume = "90",

pages = "e175--e176",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence"

AU - Ørholt, Mathias

AU - Eriksson, Frank

AU - Herly, Mikkel

AU - Vester-Glowinski, Peter

PY - 2024

Y1 - 2024

N2 - To the Editor: We thank Pham et al1 for their interest in our study on patients with atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS),2 and we appreciate the opportunity to discuss and clarify our analysis further.

AB - To the Editor: We thank Pham et al1 for their interest in our study on patients with atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS),2 and we appreciate the opportunity to discuss and clarify our analysis further.

U2 - 10.1016/j.jaad.2023.12.042

DO - 10.1016/j.jaad.2023.12.042

M3 - Comment/debate

C2 - 38185254

SN - 0190-9622

VL - 90

SP - e175-e176

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 5

ER -